US Levodopa Market Firms in July on Rising Import Costs

US Levodopa CFR Los Angeles prices increased in July **** after the correction recorded in June, as rising ex-Vapi Indian netbacks and higher India–US freight costs strengthened landed-cost pressure. The market benefited from steady procurement by US Parkinson’s treatment formulators, while the BIOSECURE Act-preferred supply route supported Indian-origin material. Freight surged sharply on the India–US corridor, with JNPT–Los Angeles container rates jumping from $*,*** to $*,*** per **-ft container, a **.*** month-on-month increase, while **-ft rates rose from $*,*** to $*,***, up **.***. China-origin Shanghai–Los Angeles freight also increased **.**, reinforcing the upward cost pressure on Levodopa imports, according to ChemAnalyst data.

Demand patterns remained relatively steady across end-use sectors. The pharmaceuticals sector, particularly generic formulators producing Levodopa-Carbidopa API for Parkinson’s disease therapies, remained the primary driver and sustained a moderate baseline of offtake as prescription volumes held steady. Retail pharmacies and larger chains...